Drugs / GM-K562
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00694330 | Jun 2008 → Aug 2009 | glioma | Massachusetts General Hospital | Completed | No outcome recorded |
| Phase 1 | NCT00442130 | Feb 2007 → Feb 2014 | B-cell chronic lymphocytic leukemia | Dana-Farber Cancer Institute | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GM-K562 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00694330 ↗ |